Colitis-associated colorectal cancer (CAC) is a major contributor to cancer-related mortality worldwide. Titanium dioxide (TiO2, E171), a widely used food additive, has been insufficiently studied regarding its effects on macrophages within colon tumors during CAC development. In this study, CAC mouse models were used to investigate the biological impact of dietary E171 on macrophages in vivo, while lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cell lines were employed to elucidate the underlying mechanisms in vitro. We found that dietary E171 intake accelerated CAC development, exacerbated inflammatory responses and oxidative stress, and upregulated CAC-associated genes, including S100a8, S100a9, Lcn2, S100a11, Cxcl2, and interleukin-1α (Il-1α). E171 also increased the expression of S100A8, S100A9, NOD-like receptor family pyrin domain-containing 3 (NLRP3), and gasdermin-D N-terminal (GSDMD-N) in macrophages within colon tumors. In inflammatory macrophages, E171 exposure enhanced cell viability, increased reactive oxygen species (ROS) levels, and elevated the expression and secretion of S100A8 and S100A9, consistent with in vivo histological observations. Furthermore, E171-induced secretion of S100A8 and S100A9 in macrophages was suppressed by specific inhibitors, including N-acetylcysteine (NAC, ROS inhibitor), MCC950 (NLRP3 inhibitor), Z-YVAD-FMK (caspase 1 inhibitor), disulfiram (GSDMD inhibitor), and transfection of NLRP3 small interfering ribonucleic acid (siRNA). These results indicate that dietary E171 promotes CAC development by activating macrophages, with S100A8 and S100A9 serving as key mediators, and the NLRP3/caspase 1/GSDMD pathway acting as a critical mechanism.
Funding
This study was supported by the National Natural Science Foundation of China (Nos. 81974441 and 82203619) and the Science and Technology Planning Project of Shenzhen Municipality (Nos. JCYJ20190814105619048 and JCYJ20220530154202005).
Supporting information
Supporting information for this work can be obtained by contacting the corresponding authors via E-mail.
Declaration of conflicting interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
| [1] |
Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023; 73(3):233-254. https://doi.org/10.3322/caac.21772.
|
| [2] |
Wesselink E, Boshuizen HC, van Lanen AS, et al. Dietary and lifestyle inflammation scores in relation to colorectal cancer recurrence and all-cause mortality: a longitudinal analysis. Clin Nutr. 2024; 43(9):2092-2101. https://doi.org/10.1016/j.clnu.2024.07.028.
|
| [3] |
Vernia F, Longo S, Stefanelli G, et al.Dietary factors modulating colorectal carcinogenesis. Nutrients. 2021; 13(1):143. https://doi.org/10.3390/nu13010143.
|
| [4] |
Martirosyan A, Schneider YJ. Engineered nanomaterials in food: implications for food safety and consumer health. Int J Environ Res Public Health. 2014; 11(6):5720-5750. https://doi.org/10.3390/ijerph110605720.
|
| [5] |
Jovanovic B. Critical review of public health regulations of titanium dioxide, a human food additive. Integr Environ Assess Manag. 2015; 11(1):10-20. https://doi.org/10.1002/ieam.1571.
|
| [6] |
Weir A, Westerhoff P, Fabricius L, et al. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol. 2012; 46(4):2242-2250. https://doi.org/10.1021/es204168d.
|
| [7] |
EFSA Panel on Food Additives and Flavourings, Younes M, Aquilina G, et al. Safety assessment of titanium dioxide (E171) as a food additive. EFSA J. 2021; 19(5):e06585. https://doi.org/10.2903/j.efsa.2021.6585.
|
| [8] |
Urrutia-Ortega IM, Garduno-Balderas LG, Delgado-Buenrostro NL, et al. Food-grade titanium dioxide exposure exacerbates tumor formation in colitis associated cancer model. Food Chem Toxicol. 2016; 93:20-31. https://doi.org/10.1016/j.fct.2016.04.014.
|
| [9] |
Blevins LK, Crawford RB, Bach A, et al. Evaluation of immunologic and intestinal effects in rats administered an E171-containing diet, a food grade titanium dioxide (TiO2). Food Chem Toxicol. 2019; 133:110793. https://doi.org/10.1016/j.fct.2019.110793.
|
| [10] |
Cao X, Han Y, Gu M, et al. Foodborne titanium dioxide nanoparticles induce stronger adverse effects in obese mice than non-obese mice: gut microbiota dysbiosis, colonic inflammation, and proteome alterations. Small. 2020; 16(36):e2001858. https://doi.org/10.1002/smll.202001858.
|
| [11] |
Waldner MJ, Neurath MF. Mechanisms of immune signaling in colitis-associated cancer. Cell Mol Gastroenterol Hepatol. 2015; 1(1):6-16. https://doi.org/10.1016/j.jcmgh.2014.11.006.
|
| [12] |
Hartnett L, Egan LJ. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis. 2012; 33(4):723-731. https://doi.org/10.1093/carcin/bgs006.
|
| [13] |
Schanen BC, Karakoti AS, Seal S, et al. Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano. 2009; 3(9):2523-2532. https://doi.org/10.1021/nn900403h.
|
| [14] |
Giovanni M, Yue J, Zhang L, et al. Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles. J Hazard Mater. 2015; 297:146-152. https://doi.org/10.1016/j.jhazmat.2015.04.081.
|
| [15] |
Cho E, Mun SJ, Kim HK, et al. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models. Acta Pharmacol Sin. 2024; 45(3):581-593. https://doi.org/10.1038/s41401-023-01188-2.
|
| [16] |
Sharma BR, Kanneganti TD.Inflammasome signaling in colorectal cancer. Transl Res. 2023; 252:45-52. https://doi.org/10.1016/j.trsl.2022.09.002.
|
| [17] |
Yu YQ, Gamez-Belmonte R, Patankar JV, et al. The role of programmed necrosis in colorectal cancer. Cancers (Basel). 2022; 14(17):4295. https://doi.org/10.3390/cancers14174295.
|
| [18] |
Parang B, Barrett CW, Williams CS. AOM/DSS model of colitis-associated cancer. Methods Mol Biol. 2016; 1422:297-307. https://doi.org/10.1007/978-1-4939-3603-8_26.
|
| [19] |
Mu W, Wang Y, Huang C, et al. Effect of long-term intake of dietary titanium dioxide nanoparticles on intestine inflammation in mice. J Agric Food Chem. 2019; 67(33):9382-9389. https://doi.org/10.1021/acs.jafc.9b02391.
|
| [20] |
Xing L, Fu L, Cao S, et al. The anti-inflammatory effect of bovine bone-gelatin-derived peptides in LPS-induced RAW264.7 macrophages cells and dextran sulfate sodium-induced C57BL/ 6 mice. Nutrients. 2022; 14(7):1479. https://doi.org/10.3390/nu14071479.
|
| [21] |
Zhang X, Ai F, Li X, et al. Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis. Int J Cancer. 2015; 137(12):2803-2814. https://doi.org/10.1002/ijc.29671.
|
| [22] |
Erben U, Loddenkemper C, Doerfel K, et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014; 7(8):4557-4576.
|
| [23] |
Ruiz PA, Moron B, Becker HM, et al. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP 3 inflammasome. Gut. 2017; 66(7):1216-1224. https://doi.org/10.1136/gutjnl-2015-310297.
|
| [24] |
Barreau F, Tisseyre C, Menard S, et al. Titanium dioxide particles from the diet: involvement in the genesis of inflammatory bowel diseases and colorectal cancer. Part Fibre Toxicol. 2021; 18(1):26. https://doi.org/10.1186/s12989-021-00421-2.
|
| [25] |
Wang P, Hu G, Zhao W, et al. Continuous ZnO nanoparticle exposure induces melanoma-like skin lesions in epidermal barrier dysfunction model mice through anti-apoptotic effects mediated by the oxidative stress-activated NF-κB pathway. J Nanobiotechnol. 2022; 20(1):111. https://doi.org/10.1186/s12951-022-01308-w.
|
| [26] |
Wang P, Zhang L, Liao Y, et al. Effect of intratracheal instillation of ZnO nanoparticles on acute lung inflammation induced by lipopolysaccharides in mice. Toxicol Sci. 2020; 173(2):373-386. https://doi.org/10.1093/toxsci/kfz234.
|
| [27] |
Chen Y, Ouyang Y, Li Z, et al. S100A8 and S100A9 in cancer. Biochim Biophys Acta Rev Cancer. 2023; 1878(3):188891. https://doi.org/10.1016/j.bbcan.2023.188891.
|
| [28] |
Pinto ML, Rios E, Duraes C, et al. The two faces of tumor-associated macrophages and their clinical significance in colorectal cancer. Front Immunol. 2019; 10:1875. https://doi.org/10.3389/fimmu.2019.01875.
|
| [29] |
Dos Anjos CA. F4/80 as a major macrophage marker: the case of the peritoneum and spleen. Results Probl Cell Differ. 2017; 62:161-179. https://doi.org/10.1007/978-3-319-54090-0_7.
|
| [30] |
Jorch SK, McNally A, Berger P, et al. Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever. J Allergy Clin Immunol. 2023; 152(1):230-243. https://doi.org/10.1016/j.jaci.2023.01.037.
|
| [31] |
Fang X, Lian H, Liu S, et al. A positive feedback cycle between the alarmin S100A8/A9 and NLRP3 inflammasome-GSDMD signalling reinforces the innate immune response in Candida albicans keratitis. Inflamm Res. 2023; 72(7):1485-1500. https://doi.org/10.1007/s00011-023-01757-5.
|
| [32] |
Bassorgun CI, Unal B, Erin N, et al. S100A8 and S100A9 positive cells in colorectal carcinoma: clinicopathological analysis. Gastroenterol Res Pract. 2014; 2014:943175. https://doi.org/10.1155/2014/943175.
|
| [33] |
Zeng ML, Zhu XJ, Liu J, et al. An integrated bioinformatic analysis of the S100 gene family for the prognosis of colorectal cancer. Biomed Res Int. 2020; 2020:4746929. https://doi.org/10.1155/2020/4746929.
|
| [34] |
Chaudhary N, Choudhary BS, Shah SG, et al. Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer. Int J Cancer. 2021; 149(7):1495-1511. https://doi.org/10.1002/ijc.33711.
|
| [35] |
Jia SN, Han YB, Yang R, et al.Chemokines in colon cancer progression. Semin Cancer Biol. 2022; 86(Pt 3): 400-407. https://doi.org/10.1016/j.semcancer.2022.02.007.
|
| [36] |
Liu L, Zhai Z, Wang D, et al. The association between IL-1 family gene polymorphisms and colorectal cancer: a meta-analysis. Gene. 2021; 769:145187. https://doi.org/10.1016/j.gene.2020.145187.
|
| [37] |
Yu W, Tu Y, Long Z, et al. Reactive oxygen species bridge the gap between chronic inflammation and tumor development. Oxid Med Cell Longev. 2022; 2022:2606928. https://doi.org/10.1155/2022/2606928.
|
| [38] |
Sreejit G, Flynn MC, Patil M, et al. S100 family proteins in inflammation and beyond. Adv Clin Chem. 2020; 98:173-231. https://doi.org/10.1016/bs.acc.2020.02.006.
|
| [39] |
Claudia M, Kristin O, Jennifer O, et al. Comparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro. Toxicology. 2017; 378:25-36. https://doi.org/10.1016/j.tox.2017.01.001.
|
| [40] |
Romeo D, Nowack B, Wick P. Combined in vitro-in vivo dosimetry enables the extrapolation of in vitro doses to human exposure levels: a proof of concept based on a meta-analysis of in vitro and in vivo titanium dioxide toxicity data. NanoImpact. 2022; 25:100376. https://doi.org/10.1016/j.impact.2021.100376.
|
| [41] |
Correa SF, Macias MFI, Velazquez DKA, et al. Food-grade titanium dioxide (E171) and zinc oxide nanoparticles induce mitochondrial permeability and cardiac damage after oral exposure in rats. Nanotoxicology. 2024; 18(2):122-133. https://doi.org/10.1080/17435390.2024.2323069.
|
| [42] |
Colin-Val Z, Vera-Marquez CD, Herrera-Rodriguez MA, et al. Titanium dioxide (E171) induces toxicity in H9c2 rat cardiomyoblasts and ex vivo rat hearts. Cardiovasc Toxicol. 2022; 22(8):713-726. https://doi.org/10.1007/s12012-022-09747-5.
|
| [43] |
Li Q, Lin L, Zhang C, et al. The progression of inorganic nanoparticles and natural products for inflammatory bowel disease. J Nanobiotechnol. 2024; 22(1):17. https://doi.org/10.1186/s12951-023-02246-x.
|
| [44] |
Xu J, Nunez G. The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023; 48(4):331-344. https://doi.org/10.1016/j.tibs.2022.10.002.
|
| [45] |
Li Z, Pan H, Yang J, et al. Xuanfei Baidu Formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models. Phytomedicine. 2023; 108:154545. https://doi.org/10.1016/j.phymed.2022.154545.
|
| [46] |
Li JM, Deng HS, Yao YD, et al. Sinomenine ameliorates collagen-induced arthritis in mice by targeting GBP5 and regulating the P2X7 receptor to suppress NLRP3-related signaling pathways. Acta Pharmacol Sin. 2023; 44(12):2504-2524. https://doi.org/10.1038/s41401-023-01124-4.
|
| [47] |
Xu Z, Hu H, Wang K, et al. Sinensetin, a polymethoxyflavone from citrus fruits, ameliorates LPS-induced acute lung injury by suppressing Txnip/NLRP3/Caspase-1/GSDMD signaling-mediated inflammatory responses and pyroptosis. Food Funct. 2024; 15(14):7592-7604. https://doi.org/10.1039/D4FO01704H.
|
| [48] |
Ball DP, Taabazuing CY, Griswold AR, et al. Caspase-1 interdomain linker cleavage is required for pyroptosis. Life Sci Alliance. 2020; 3(3):e202000664. https://doi.org/10.26508/lsa.202000664.
|
| [49] |
Fu J, Schroder K, Wu H.Mechanistic insights from inflammasome structures. Nat Rev Immunol. 2024; 24(7):518-535. https://doi.org/10.1038/s41577-024-00995-w.
|
PDF
(10851KB)
